EP1.01-13 A Phase 2 Trial Assessing Osimertinib Activity Against Leptomeningeal Carcinomatosis in EGFR-Mutant Lung Cancer

Saved in:
Bibliographic Details
Published inJournal of thoracic oncology Vol. 14; no. 10; p. S918
Main Authors Akazawa, Y., Nanjo, S., Tamiya, M., Hata, A., Yamaguchi, T., Kumagai, T., Mori, M., Katakami, N.
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.10.2019
Online AccessGet full text

Cover

More Information
ISSN:1556-0864
1556-1380
DOI:10.1016/j.jtho.2019.08.1992